A NEW SURGICAL OUTCOME SCORE (SOS) INCLUDING HE4, CA125 AND ASCITES VOLUME CAN PREDICT SURGICAL OUTCOME IN PRIMARY OVARIAN CANCER PATIENTS.

被引：0
|
作者：
Braicu, E. [1 ]
van Gorp, T. [2 ]
Richter, R. [1 ]
Nassir, M. [3 ]
Zeillinger, R. [4 ]
Conicn, N. [5 ]
Tong, D. Cacsire Castillo [4 ]
Mahner, S. [6 ]
Vergote, I. [7 ]
Sehouli, J. [1 ]
机构：
[1] Charite, Dept Gynaecol, D-13353 Berlin, Germany
[2] Univ Hosp Maastricht, Dept Obstet & Gynaecol, Maastricht, Netherlands
[3] Charite Campus Virchow, Dept Gynaecol, Berlin, Germany
[4] Med Univ Vienna, Mol Oncol Grp, Vienna, Austria
[5] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[6] Med Univ Hamburg, Clin Gynecol, Hamburg, Germany
[7] Univ Hosp KU Leuven, Dept Obstet & Gynaecol, Louvain, Belgium
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Surgical outcome score (SOS), a new algorithm based on HE4 and CA125, to predict surgical outcome in primary epithelial ovarian cancer (EOC) patients (pts)
    Braicu, Elena Ioana
    van Gorp, Toon
    Richter, Rolf
    Chekerov, Radoslav
    Timmerman, Dirk
    Nassir, Mani
    Sehouli, Jalid
    Vergote, Ignace
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer
    Shen, Ying
    Li, Li
    TUMOR BIOLOGY, 2016, 37 (11) : 14765 - 14772
  • [3] Defining a prognostic risk score in ovarian cancer patients by integrated analysis of serum mesothelin, HE4, CA125 and surgical outcome.
    Wimberger, Pauline
    Klotz, Daniel
    Goeckenjan, Maren
    Link, Theresa
    Kuhlmann, Jan Dominik
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17611 - E17611
  • [4] HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Kotowicz, B.
    Fuksiewicz, M.
    Kowalska, M.
    Sobiczewski, P.
    Skrzypczak, M.
    Spiewankiewicz, B.
    Kaminska, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [5] Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
    Andersen, M. Robyn
    Goff, Barbara A.
    Lowe, Kimberly A.
    Scholler, Nathalie
    Bergan, Lindsay
    Drescher, Charles W.
    Paley, Pamela
    Urban, Nicole
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 378 - 383
  • [6] Use of HE4 and CA125 to predict surgical outcome and for prognostic value for progression-free survival (PFS) and overall survival (OS) in primary epithelial ovarian cancer (EOC) patients (pts)
    Braicu, Ioana
    Chekerov, Radoslav
    Richter, Rolf
    Vergote, Ignace B.
    Mahner, Sven
    Zeimet, Alain G.
    Ganapathi, Ram N.
    Woelber, Linn Lena
    Castillo-Tong, Dan Cacsire
    Cadron, Isabelle
    Zeillinger, Robert
    Fotopoulou, Christina
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] INCORPORATING HE4 AND CA125 INTO AN ENDOMETRIAL CANCER SURGICAL REFERRAL ALGORITHM
    Kalogera, E.
    Weaver, A. L.
    Bakkum-Gamez, J. N.
    Cliby, W. A.
    Mariani, A.
    Podratz, K. C.
    Dowdy, S. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1510 - 1511
  • [8] A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin)
    Klotz, Daniel Martin
    Link, Theresa
    Wimberger, Pauline
    Kuhlmann, Jan Dominik
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (03) : 530 - 539
  • [9] A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin)
    Kuhlmann, J. D.
    Klotz, B. M.
    Link, T.
    Wimberger, P.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (06) : E32 - E33
  • [10] DISEASE RELAPSE IN OVARIAN CANCER PATIENTS DETECTED BY HE4 AND CA125
    Steffensen, K.
    Waldstrom, M.
    Brandslund, I.
    Lund, B.
    Sorensen, S. M.
    Petzold, M.
    Jakobsen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 187 - 188
12345